APGE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 136688 min ago

@ $35.28

Išleistas: 14 vas. 2024 @ 22:02

Grąža: 42.60%

Ankstesnis signalas: vas. 13 - 19:37

Ankstesnis signalas: Pardavimas

Grąža: 0.28 %

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	379 725
Vidutinė apimtis	711 880
Rinkos kapitalizacija	2.94B
EPS	$0 ( 2024-03-11 )
Kita pelno data	( $-0.600 ) 2024-06-04
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0850 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-29	Fairmount Funds Management Llc	Buy	51 166	Common Stock
2024-01-29	Fairmount Funds Management Llc	Sell	892 529	Common Stock
2023-12-18	Henderson Michael Thomas	Buy	398 512	Stock Option (Right to Buy)
2023-07-13	Fairmount Funds Management Llc	Buy	1 992 734	Common Stock
2023-07-13	Fairmount Funds Management Llc	Buy	892 529	Common Stock

INSIDER POWER
47.02
Last 9 transactions
Buy: 3 438 612 \| Sell: 892 529

Tūris Koreliacija

Ilgas: -0.38 (neutral)

Trumpas: -0.67 (moderate negative)

Signal:(42.984) Neutral

Apogee Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Apogee Therapeutics, Inc. Koreliacija - Valiuta/Žaliavos

-0.78
( moderate negative )

-0.67
( moderate negative )

-0.78
( moderate negative )

-0.71
( moderate negative )

-0.73
( moderate negative )

0.72
( moderate )

Apogee Therapeutics, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-1.660

FY	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-1.660

FY	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-0.790

Financial Reports:

No articles found.

Apogee Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.